Temat: "Drug Administration Schedule" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials.
Autorzy :: Imperial MZ; Department of Bioengineering and Therapeutic Sciences.; University of California, San Francisco, Center for Tuberculosis, and.
Phillips PPJ; University of California, San Francisco, Center for Tuberculosis, and.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California.
Nahid P; University of California, San Francisco, Center for Tuberculosis, and.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California.
Savic RM; Department of Bioengineering and Therapeutic Sciences.; University of California, San Francisco, Center for Tuberculosis, and.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California.; Pokaż więcej
Źródło :: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Nov 01; Vol. 204 (9), pp. 1086-1096.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Administration Schedule*
Duration of Therapy*
Antitubercular Agents/*standards
Clinical Trials as Topic/*standards
Precision Medicine/*standards
Rifampin/*standards
Tuberculosis, Pulmonary/*drug therapy
Adult ; Antitubercular Agents/therapeutic use ; Female ; Humans ; Male ; Practice Guidelines as Topic ; Rifampin/therapeutic use ; Risk Assessment/standards ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
Autorzy :: Taylor WR; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand. .; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. .
Hoglund RM; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Peerawaranun P; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.
Nguyen TN; Oxford University Clinical Research Unit, Wellcome Trust Major Oversea Programme, Ho Chi Minh City, Vietnam.
Hien TT; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Clinical Research Unit, Wellcome Trust Major Oversea Programme, Ho Chi Minh City, Vietnam.
Tarantola A; Institut Pasteur du Cambodge, 5 Monivong Boulevard, Phnom Penh, 12201, Cambodia.
von Seidlein L; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Tripura R; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Global Health, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Peto TJ; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Dondorp AM; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Landier J; Shoklo Malaria Research Unit, Mae Sot, Thailand.; Aix-Marseille Université, IRD, INSERM, SESSTIM, Marseille, France.
H Nosten F; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Shoklo Malaria Research Unit, Mae Sot, Thailand.
Smithuis F; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Phommasone K; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.; Amsterdam Institute for Global Health & Development, Amsterdam, The Netherlands.
Mayxay M; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.; Institute of Research and Education Development, University of Health Sciences, Vientiane, Lao PDR.
Kheang ST; Center for Health and Social Development (HSD), National Institute for Public Health (NIPH) and University Research Co., LLC (URC), Chey Chumneas, Daun Penh, Phnom Penh, Cambodia.; AQUITY Global Inc, 987 Avenel Farm Dr, Potomac, MD, 20854, USA.
Say C; Center for Health and Social Development (HSD), National Institute for Public Health (NIPH) and University Research Co., LLC (URC), Chey Chumneas, Daun Penh, Phnom Penh, Cambodia.
Neeraj K; University Research Co., LLC Washington DC, 7200 Wisconsin Ave, Bethesda, MD, 20814, USA.
Rithea L; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.
Dysoley L; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.; Institute of Public Health, Phnom Penh, Cambodia.
Kheng S; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.
Muth S; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.
Roca-Feltrer A; Malaria Consortium, London, UK.
Debackere M; MSF Belgium Cambodia Malaria Program, Khan Chamkarmon, Phnom Penh, Cambodia.
Fairhurst RM; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
Song N; FHI 360 Cambodia Office, Keng Kang III Khan Chamkamon, Phnom Penh, Cambodia.
Buchy P; Institut Pasteur du Cambodge, 5 Monivong Boulevard, Phnom Penh, 12201, Cambodia.; GSK Vaccines, 23 Rochester Park, Singapore, Singapore.
Menard D; Institut Pasteur du Cambodge, 5 Monivong Boulevard, Phnom Penh, 12201, Cambodia.; Unité Génétique du Paludisme Et Résistance, Département Parasites Et Insectes Vecteurs, Institut Pasteur, Paris, France.
White NJ; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Tarning J; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mukaka M; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Pokaż więcej
Źródło :: Malaria journal [Malar J] 2021 Sep 09; Vol. 20 (1), pp. 366. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Administration Schedule*
Antimalarials/*administration & dosage
Malaria, Vivax/*prevention & control
Plasmodium vivax/*drug effects
Primaquine/*administration & dosage
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Body Weight ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Middle Aged ; Young Adult
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration.
Autorzy :: Denesh D; Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Carbonell J; Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Kane JS; Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Gracie D; Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Selinger CP; Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.; Pokaż więcej
Źródło :: Expert review of gastroenterology & hepatology [Expert Rev Gastroenterol Hepatol] 2021 Sep; Vol. 15 (9), pp. 1091-1096. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Administration Routes*
Drug Administration Schedule*
Patient Preference*
Inflammatory Bowel Diseases/*drug therapy
Administration, Oral ; Ambulatory Care ; Biological Products/administration & dosage ; Female ; Home Care Services ; Humans ; Infusions, Intravenous ; Injections, Subcutaneous ; Male ; Medication Adherence ; Middle Aged ; Nurse's Role ; Self Administration ; Surveys and Questionnaires ; Tablets
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Complexity of Medication Regimens for Children With Neurological Impairment.
Autorzy :: Feinstein JA; Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado and Children's Hospital Colorado, Aurora.; Department of Pediatrics, University of Colorado, Aurora.
Friedman H; Pediatric Residency Program, University of Colorado, Aurora.
Orth LE; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora.
Feudtner C; Division of General Pediatrics, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Kempe A; Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado and Children's Hospital Colorado, Aurora.; Department of Pediatrics, University of Colorado, Aurora.
Samay S; Research Informatics, Analytics Resource Center, Children's Hospital Colorado, Aurora.
Blackmer AB; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora.; Pokaż więcej
Źródło :: JAMA network open [JAMA Netw Open] 2021 Aug 02; Vol. 4 (8), pp. e2122818. Date of Electronic Publication: 2021 Aug 02.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Drug Administration Schedule*
Chronic Disease/*drug therapy
Medication Adherence/*statistics & numerical data
Nervous System Diseases/*drug therapy
Adolescent ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Humans ; Infant ; Male ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: A New Normal Once Again.
Autorzy :: Hageman JR; Pokaż więcej
Źródło :: Pediatric annals [Pediatr Ann] 2021 Jul; Vol. 50 (7), pp. e268-e269. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji :: Editorial; Comment
MeSH Terms :: Drug Administration Schedule*
Humans
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy.
Autorzy :: Hsu T; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Department of Medicine, The University of Ottawa, Ottawa, Canada.
Fergusson D; Department of Medicine, The University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Stober C; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Daigle K; Department of Nursing, The Ottawa Hospital and the Ottawa Hospital Cancer Centre, Ottawa, Canada.
Moledina N; Department of Nursing, The Ottawa Hospital and the Ottawa Hospital Cancer Centre, Ottawa, Canada.
Vandermeer L; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Pond G; Department of Oncology, McMaster University, Hamilton, Canada.
Hilton J; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Department of Medicine, The University of Ottawa, Ottawa, Canada.
Hutton B; Department of Medicine, The University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Clemons M; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada. .; Department of Medicine, The University of Ottawa, Ottawa, Canada. .; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. .; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada. .; Pokaż więcej
Corporate Authors :: REaCT investigators
Źródło :: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Jun; Vol. 29 (6), pp. 3113-3120. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Drug Administration Schedule*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Dexamethasone/*therapeutic use
Docetaxel/*therapeutic use
Glucocorticoids/*therapeutic use
Premedication/*methods
Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Dexamethasone/pharmacology ; Docetaxel/pharmacology ; Female ; Glucocorticoids/pharmacology ; Humans ; Male ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Autorzy :: van Gerwen M; Center for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Maggen C; Department of Oncology, KU Leuven, Leuven, Belgium.
Cardonick E; Department of Obstetrics and Gynecology, Cooper University Health Care, Camden, New Jersey.
Verwaaijen EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
van den Heuvel-Eibrink M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Shmakov RG; National Medical Research Centre for Obstetrics, Gynaecology and Perinatology named after Academician V.I. Kulakov, Ministry of Healthcare of Russian Federation, Moscow, Russia.
Boere I; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Gziri MM; Department of Obstetrics, Cliniques Universitaires St Luc, Université Catholique de Louvain, Sint-Lambrechts-Woluwe, Belgium.
Ottevanger PB; Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
Lok CAR; Center for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.; Center for Gynecological Oncology Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Halaska M; University Hospital Kralovske Vinohrady, Third Medical Faculty, Charles University, Prague, Czech Republic.
Shao LT; Cooper Medical School, Rowan University, Camden, New Jersey.
Struys I; Department of Oncology, KU Leuven, Leuven, Belgium.
van Dijk-Lokkart EM; Department of Child and Adolescent Psychiatry & Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Van Calsteren K; Department of Obstetrics, University Hospitals, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Fruscio R; Department of Obstetrics and Gynecology, San Gerardo Hospital, Milan, Italy.
Zola P; Department of Surgical Sciences, University of Turin, Turin, Italy.
Scarfone G; Gynecological Oncology Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy.
Amant F; Center for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Oncology, KU Leuven, Leuven, Belgium.; Center for Gynecological Oncology Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Pokaż więcej
Corporate Authors :: International Network on Cancer, Infertility and Pregnancy
Źródło :: JAMA network open [JAMA Netw Open] 2021 Jun 01; Vol. 4 (6), pp. e2113180. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Administration Schedule*
Abnormalities, Drug-Induced/*etiology
Antineoplastic Agents/*adverse effects
Antineoplastic Agents/*therapeutic use
Fetal Development/*drug effects
Neoplasms/*drug therapy
Adolescent ; Adult ; Cohort Studies ; Female ; Gestational Age ; Humans ; Middle Aged ; Odds Ratio ; Pregnancy ; Pregnancy Trimester, First ; Pregnant Women ; Time Factors ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study.
Autorzy :: Suehs CM; Département des Maladies Respiratoires and.
Menzies-Gow A; PhyMedExp, Université de Montpellier, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire Montpellier, Montpellier, France.
Price D; Royal Brompton and Harefield National Health Service Foundation Trust, London, United Kingdom.; Observational and Pragmatic Research Institute, Singapore.
Bleecker ER; Division of Applied Health Sciences, Centre of Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom.
Canonica GW; Department of Medicine, University of Arizona, Tucson, Arizona.
Gurnell M; Personalized Medicine, Asthma and Allergy Center, Humanitas University and IRCCS Research Hospital, Milan, Italy; and.; Wellcome Trust-Medical Research Council Institute of Metabolic Science and.
Bourdin A; Département des Maladies Respiratoires and.; Cambridge National Institute for Health Research Biomedical Research Centre, University of Cambridge and Addenbrooke's Hospital, Cambridge, United Kingdom.; Pokaż więcej
Corporate Authors :: Oral Corticosteroids Tapering Delphi Expert Panel
Źródło :: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Apr 01; Vol. 203 (7), pp. 871-881.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Administration Schedule*
Expert Testimony*
Adrenal Cortex Hormones/*administration & dosage
Adrenal Cortex Hormones/*standards
Adrenal Cortex Hormones/*therapeutic use
Asthma/*drug therapy
Administration, Oral ; Adult ; Consensus ; Delphi Technique ; Female ; Humans ; Male ; Middle Aged ; Practice Guidelines as Topic
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Effectiveness of scheduled intravenous acetaminophen in the postoperative pain management of video-assisted thoracic surgery.
Autorzy :: Shikatani Y; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Soh J; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan. .
Shien K; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Kurosaki T; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Ohtani S; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Yamamoto H; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Taniguchi A; Anesthesiology and Resuscitology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, Japan.
Okazaki M; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Sugimoto S; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Yamane M; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Oto T; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Morimatsu H; Anesthesiology and Resuscitology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, Japan.
Toyooka S; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.; Pokaż więcej
Źródło :: Surgery today [Surg Today] 2021 Apr; Vol. 51 (4), pp. 589-594. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Administration Schedule*
Acetaminophen/*administration & dosage
Analgesics, Non-Narcotic/*administration & dosage
Pain, Postoperative/*drug therapy
Pain, Postoperative/*etiology
Pneumonectomy/*adverse effects
Thoracic Surgery, Video-Assisted/*adverse effects
Female ; Humans ; Infusions, Intravenous ; Male ; Pneumonectomy/methods ; Retrospective Studies ; Safety ; Thoracic Surgery, Video-Assisted/methods ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Bisphosphonate Drug Holidays in Primary Care: When and What to Do Next?
Autorzy :: Bauer DC; University of California, San Francisco, 1545 Divisadero, 3rd floor, San Francisco, CA, 94143, USA. .
Abrahamsen B; University of Southern Denmark, Odense, Denmark.; Pokaż więcej
Źródło :: Current osteoporosis reports [Curr Osteoporos Rep] 2021 Apr; Vol. 19 (2), pp. 182-188. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Drug Administration Schedule*
Primary Health Care*
Bone Density Conservation Agents/*administration & dosage
Osteoporosis/*drug therapy
Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
Autorzy :: Rubino DM; Washington Center for Weight Management and Research, Arlington, Virginia.
Greenway FL; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge.
Khalid U; Novo Nordisk A/S, Søborg, Denmark.
O'Neil PM; Weight Management Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston.
Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, Texas.
Sørrig R; Novo Nordisk A/S, Søborg, Denmark.
Wadden TA; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Wizert A; Novo Nordisk A/S, Søborg, Denmark.
Garvey WT; Department of Nutrition Sciences, University of Alabama at Birmingham.; Pokaż więcej
Corporate Authors :: STEP 8 Investigators
Źródło :: JAMA [JAMA] 2022 Jan 11; Vol. 327 (2), pp. 138-150.
Typ publikacji :: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :: Body Weight/*drug effects
Glucagon-Like Peptides/*administration & dosage
Hypoglycemic Agents/*administration & dosage
Liraglutide/*administration & dosage
Overweight/*drug therapy
Diabetes Mellitus ; Diet Therapy ; Drug Administration Schedule ; Exercise ; Female ; Glucagon-Like Peptides/adverse effects ; Humans ; Hypoglycemic Agents/adverse effects ; Injections, Subcutaneous ; Liraglutide/adverse effects ; Male ; Middle Aged ; Obesity/drug therapy ; Obesity/therapy ; Odds Ratio ; Overweight/therapy ; Patient Dropouts/statistics & numerical data ; Placebos/administration & dosage ; Treatment Outcome ; United States ; Weight Loss
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
Autorzy :: Goldenberg NA; Institute for Clinical and Translational Research, Cancer and Blood Disorder Institute, and Heart Institute, Johns Hopkins All Children's Hospital, St Petersburg, Florida.; Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland.; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Kittelson JM; Department of Biostatistics, School of Public Health, University of Colorado Anschutz Medical Campus, Aurora.; CPC Clinical Research, Aurora, Colorado.
Abshire TC; Versiti Blood Research Institute and Department of Pediatrics and Medicine and Clinical and Translational Science Institute, Medical College of Wisconsin, Milwaukee.
Bonaca M; CPC Clinical Research, Aurora, Colorado.; Division of Cardiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora.
Casella JF; Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Dale RA; CPC Clinical Research, Aurora, Colorado.
Halperin JL; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Hamblin F; Institute for Clinical and Translational Research, Cancer and Blood Disorder Institute, and Heart Institute, Johns Hopkins All Children's Hospital, St Petersburg, Florida.
Kessler CM; Lombardi Cancer Center, Department of Medicine, School of Medicine, Georgetown University, Washington, DC.
Manco-Johnson MJ; Department of Pediatrics, School of Medicine, Children's Hospital of Colorado, Hemophilia and Thrombosis Center, University of Colorado Anschutz Medical Campus, Aurora.
Sidonio RF; Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia.
Spyropoulos AC; Department of Medicine, Zucker School of Medicine at Hofstra/Northwell and Feinstein Institutes for Medical Research, Manhasset, New York.; Department of Obstetrics and Gynecology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
Steg PG; Université de Paris, AP-HP, Hôpital Bichat, French Alliance for Cardiovascular Trials and INSERM 1148, Paris, France.
Turpie AGG; Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada.
Schulman S; Department of Obstetrics and Gynecology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.; Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada.; Pokaż więcej
Corporate Authors :: Kids-DOTT Trial Investigators and the ATLAS Group
Źródło :: JAMA [JAMA] 2022 Jan 11; Vol. 327 (2), pp. 129-137.
Typ publikacji :: Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Anticoagulants/*administration & dosage
Hemorrhage/*chemically induced
Venous Thromboembolism/*drug therapy
Adolescent ; Age Factors ; Anticoagulants/adverse effects ; Child ; Child, Preschool ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Humans ; Incidence ; Infant ; Infant, Newborn ; Kaplan-Meier Estimate ; Male ; Recurrence ; Therapeutics ; Time Factors ; Venous Thromboembolism/etiology ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Long-acting injectable for HIV approved for use in the UK.
Autorzy :: Kirby T; Pokaż więcej
Źródło :: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Jan; Vol. 22 (1), pp. 26.
Typ publikacji :: Journal Article
MeSH Terms :: Injections*
Anti-HIV Agents/*therapeutic use
Delayed-Action Preparations/*therapeutic use
HIV/*drug effects
HIV Infections/*drug therapy
Anti-HIV Agents/administration & dosage ; Drug Administration Schedule ; HIV Infections/prevention & control ; Humans ; Pre-Exposure Prophylaxis/methods ; Pyridones/therapeutic use ; Rilpivirine/therapeutic use ; United Kingdom
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Effectiveness of epidural steroid injection in patients with lumbar herniated intervertebral disc under a "wait-and-see" policy.
Autorzy :: Kim BR; Department of Radiology, Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Lee JW; Department of Radiology, Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Lee E; Department of Radiology, Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Kang Y; Department of Radiology, Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Ahn JM; Department of Radiology, Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Kang HS; Department of Radiology, Seoul National University Bundang Hospital, Seoul, Republic of Korea.; Pokaż więcej
Źródło :: Acta radiologica (Stockholm, Sweden : 1987) [Acta Radiol] 2022 Jan; Vol. 63 (1), pp. 67-75. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji :: Journal Article
MeSH Terms :: Injections, Epidural*
Intervertebral Disc Displacement/*drug therapy
Steroids/*administration & dosage
Drug Administration Schedule ; Female ; Fluoroscopy ; Humans ; Intervertebral Disc Displacement/diagnostic imaging ; Lumbar Vertebrae/diagnostic imaging ; Male ; Middle Aged ; Time Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.
Autorzy :: Yue L; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Xie T; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Yang T; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Zhou J; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Chen H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Zhu H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Li H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Xiang H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Wang J; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Yang H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Zhao H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Wei X; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Zhang Y; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Xie Z; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.; Pokaż więcej
Źródło :: Journal of medical virology [J Med Virol] 2022 Jan; Vol. 94 (1), pp. 35-38. Date of Electronic Publication: 2021 Sep 22.
Typ publikacji :: Letter; Research Support, Non-U.S. Gov't
MeSH Terms :: Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
COVID-19 Vaccines/*immunology
Immunization, Secondary/*methods
SARS-CoV-2/*immunology
Vaccines, Inactivated/*immunology
COVID-19/prevention & control ; Drug Administration Schedule ; Humans
: Raport

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial.
Autorzy :: Landier W; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: .
Bhatia S; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Wong FL; Department of Population Sciences, City of Hope, Duarte, CA, USA.
York JM; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Flynn JS; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Henneberg HM; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Singh P; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Adams K; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Wasilewski-Masker K; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
Cherven B; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
Jasty-Rao R; Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.
Leonard M; Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.
Connelly JA; Department of Pediatrics, Vanderbilt University, Nashville, TN, USA.
Armenian SH; Department of Population Sciences, City of Hope, Duarte, CA, USA.
Robison LL; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Giuliano AR; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA.
Hudson MM; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Klosky JL; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.; Pokaż więcej
Źródło :: The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2022 Jan; Vol. 6 (1), pp. 38-48. Date of Electronic Publication: 2021 Nov 10.
Typ publikacji :: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Immunogenicity, Vaccine*
Papillomavirus Infections*/immunology
Papillomavirus Infections*/prevention & control
Patient Safety*
Cancer Survivors/*statistics & numerical data
Papillomavirus Vaccines/*administration & dosage
Adolescent ; Adult ; Drug Administration Schedule ; Female ; Human papillomavirus 16/immunology ; Human papillomavirus 18/immunology ; Humans ; Male ; United States ; Vaccines, Combined/administration & dosage ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction.
Autorzy :: Sukeishi A; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
Itohara K; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
Yonezawa A; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.; Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Sato Y; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
Matsumura K; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
Katada Y; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
Nakagawa T; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
Hamada S; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tanabe N; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Imoto E; Shimadzu Corporation, Kyoto, Japan.
Kai S; Department of Anesthesia, Kyoto University Hospital, Kyoto, Japan.
Hirai T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yanagita M; Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
Ohtsuru S; Department of Primary Care and Emergency Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Terada T; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
Ito I; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Pokaż więcej
Źródło :: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2022 Jan; Vol. 11 (1), pp. 94-103. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Adenosine/*analogs & derivatives
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
COVID-19/*drug therapy
Kidney Diseases/*blood
Adenosine/blood ; Adenosine Monophosphate/administration & dosage ; Adenosine Monophosphate/pharmacokinetics ; Aged ; Aged, 80 and over ; Alanine/administration & dosage ; Alanine/pharmacokinetics ; Body Surface Area ; COVID-19/blood ; Drug Administration Schedule ; Extracorporeal Membrane Oxygenation ; Female ; Glomerular Filtration Rate ; Humans ; Japan ; Male ; Middle Aged ; Monte Carlo Method ; Precision Medicine ; Retrospective Studies
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 18 18.

Tytuł :: Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
Autorzy :: Afolabi MO; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone. Electronic address: .
Ishola D; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone.
Manno D; London School of Hygiene & Tropical Medicine, London, UK.
Keshinro B; Janssen Vaccines and Prevention BV, Leiden, Netherlands.
Bockstal V; Janssen Vaccines and Prevention BV, Leiden, Netherlands.
Rogers B; EBOVAC Project, Kambia, Kambia district, Sierra Leone; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Owusu-Kyei K; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone.
Serry-Bangura A; EBOVAC Project, Kambia, Kambia district, Sierra Leone; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Swaray I; EBOVAC Project, Kambia, Kambia district, Sierra Leone; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Lowe B; London School of Hygiene & Tropical Medicine, London, UK; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Kowuor D; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone.
Baiden F; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone.
Mooney T; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone.
Smout E; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone.
Köhn B; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone.
Otieno GT; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone.
Jusu M; London School of Hygiene & Tropical Medicine, London, UK; EBOVAC Project, Kambia, Kambia district, Sierra Leone; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Foster J; London School of Hygiene & Tropical Medicine, London, UK.
Samai M; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Deen GF; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Larson H; London School of Hygiene & Tropical Medicine, London, UK; Department of Health Metrics Sciences, University of Washington, Seattle, WA, USA.
Lees S; London School of Hygiene & Tropical Medicine, London, UK.
Goldstein N; Janssen Vaccines and Prevention BV, Leiden, Netherlands.
Gallagher KE; London School of Hygiene & Tropical Medicine, London, UK.
Gaddah A; Janssen Research & Development, Beerse, Belgium.
Heerwegh D; Janssen Research & Development, Beerse, Belgium.
Callendret B; Janssen Vaccines and Prevention BV, Leiden, Netherlands.
Luhn K; Janssen Vaccines and Prevention BV, Leiden, Netherlands.
Robinson C; Janssen Vaccines and Prevention BV, Leiden, Netherlands.
Greenwood B; London School of Hygiene & Tropical Medicine, London, UK.
Leyssen M; Janssen Vaccines and Prevention BV, Leiden, Netherlands.
Douoguih M; Janssen Vaccines and Prevention BV, Leiden, Netherlands.
Leigh B; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Watson-Jones D; London School of Hygiene & Tropical Medicine, London, UK; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.; Pokaż więcej
Corporate Authors :: EBL3001 study group
Źródło :: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Jan; Vol. 22 (1), pp. 110-122. Date of Electronic Publication: 2021 Sep 13.
Typ publikacji :: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Immunogenicity, Vaccine*
Antibodies, Viral/*blood
Ebola Vaccines/*administration & dosage
Ebola Vaccines/*immunology
Ebolavirus/*immunology
Vaccines, DNA/*administration & dosage
Viral Vaccines/*administration & dosage
Adolescent ; Child ; Child, Preschool ; Drug Administration Schedule ; Female ; Humans ; Infant ; Injections, Intramuscular ; Male ; Sierra Leone ; Vaccines, DNA/genetics ; Vaccines, DNA/immunology ; Viral Vaccines/genetics ; Viral Vaccines/immunology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis.
Autorzy :: Floris A; Rheumatology Unit, Azienda Ospedaliero-Universitaria di Cagliari, SS554, 09042, Monserrato, Cagliari, Italy. .; Dipartimento Di Scienze Mediche E Sanità Pubblica, Università Di Cagliari, SS554, 09042, Monserrato, Cagliari, Italy. .
Piga M; Rheumatology Unit, Azienda Ospedaliero-Universitaria di Cagliari, SS554, 09042, Monserrato, Cagliari, Italy.
Chessa E; Rheumatology Unit, Azienda Ospedaliero-Universitaria di Cagliari, SS554, 09042, Monserrato, Cagliari, Italy.
Congia M; Rheumatology Unit, Azienda Ospedaliero-Universitaria di Cagliari, SS554, 09042, Monserrato, Cagliari, Italy.
Erre GL; Rheumatology Unit, University of Sassari and AOU University Clinic of Sassari, Sassari, Italy.
Angioni MM; Rheumatology Unit, Azienda Ospedaliero-Universitaria di Cagliari, SS554, 09042, Monserrato, Cagliari, Italy.
Mathieu A; Rheumatology Unit, Azienda Ospedaliero-Universitaria di Cagliari, SS554, 09042, Monserrato, Cagliari, Italy.
Cauli A; Rheumatology Unit, Azienda Ospedaliero-Universitaria di Cagliari, SS554, 09042, Monserrato, Cagliari, Italy.; Pokaż więcej
Źródło :: Clinical rheumatology [Clin Rheumatol] 2022 Jan; Vol. 41 (1), pp. 19-31. Date of Electronic Publication: 2021 Aug 20.
Typ publikacji :: Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :: Giant Cell Arteritis*/drug therapy
Polymyalgia Rheumatica*/drug therapy
Drug Administration Schedule ; Female ; Glucocorticoids/therapeutic use ; Humans ; Recurrence
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Primary herpetic gingivostomatitis in children.
Autorzy :: Heliotis I; The Royal London Dental Hospital, London, UK .
Whatling R; The Royal London Dental Hospital, London, UK.
Desai S; Birmingham Dental Hospital, Birmingham, UK.
Visavadia M; Watford Health Centre, Watford, UK.; Pokaż więcej
Źródło :: BMJ (Clinical research ed.) [BMJ] 2021 Dec 31; Vol. 375, pp. e065540. Date of Electronic Publication: 2021 Dec 31.
Typ publikacji :: Journal Article
MeSH Terms :: Stomatitis, Herpetic/*diagnosis
Acyclovir/administration & dosage ; Acyclovir/therapeutic use ; Child ; Child Health Services ; Drug Administration Schedule ; Humans ; Stomatitis, Herpetic/drug therapy
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Drug Administration Schedule"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język